Nov.13 -- Blackstone Group Inc. Chairman and Chief Executive Officer Stephen Schwarzman describes how he pushed back on his rejection from Harvard when he was a senior in high school. Schwarzman appears on "The David Rubenstein Show: Peer-to-Peer Conversations." The show was recorded on Sept. 4 in New York.
The Dow Jones fell as Elon Musk made a Tesla move. The Donald Trump stock sank on the stock market today. Cathie Wood bought a diving stock.
I am a dividend investor, and I prize dividend consistency. I just can't trust what this high-yield income stock says about its dividend.
David Tepper is one of the best-performing hedge fund managers.
Investors rarely get a chance to buy growth stocks at such depressed valuations.
Tesla has announced a large reduction in staff on the heels of a disappointing Q1 delivery report, following in the footsteps of legacy automakers and pure-play EV makers, per an internal memo.
You can invest along with Carl Icahn with this stock.
Say that, as a married couple, you have $1.4 million in your IRAs and, at age 66, expect about $4,100 per month in Social Security. Based on some typical rules of thumb, you might be able to plan on about $108,000 per year of retirement income, but how much you actually need and will be […] The post We're 66 With $1.4 Million in IRAs, and $4,100 Monthly From Social Security. What's Our Retirement Budget? appeared first on SmartReads by SmartAsset.
Enbridge (ENB) concluded the recent trading session at $33.75, signifying a -1.26% move from its prior day's close.
California fast-food employees started earning a minimum of $20 an hour in April. Thanks to a new law, which went into effect earlier this month, California chain restaurants with at least 60 locations nationwide have to pay their employees more. For smaller restaurants, the minimum wage continues to be the statewide bottom of $16 an hour. The largest publicly-traded fast-food companies include McDonald’s Corp (NYSE:MCD); Starbucks Corp (NASDAQ:SBUX); Yum! Brands, Inc. (NYSE:YUM), which owns Tac
Intra-Cellular Therapies stock rocketed Tuesday after its drug, Caplyta, topped expectations in a depression treatment study.